Mitomycin C carrying microspheres as a novel method of drug delivery.

S Fujimoto, M Miyazaki, F Endoh, O Takahashi, K Okui, K Sugibayashi, Y Morimoto
{"title":"Mitomycin C carrying microspheres as a novel method of drug delivery.","authors":"S Fujimoto,&nbsp;M Miyazaki,&nbsp;F Endoh,&nbsp;O Takahashi,&nbsp;K Okui,&nbsp;K Sugibayashi,&nbsp;Y Morimoto","doi":"10.1089/cdd.1985.2.173","DOIUrl":null,"url":null,"abstract":"<p><p>Biodegradable albumin microspheres containing about 5% mitomycin C (MMC) were prepared in an average diameter of 45 +/- 8 microns by heat denaturation in oil at 120 degrees C and/or cross-linking with glutaraldehyde. These MMC microspheres released, in vitro, about 20% of the contained MMC for over 3 days, and they were intra-arterially infused into albino rabbits and Wistar rats, as a preclinical model of intra-arterial infusion treatment for patients with inoperable hepatic tumor. We infused these microspheres into the femoral artery of rabbits with a VX-2 tumor implanted into the flank of the hindleg. High levels of MMC were maintained for several hours in the tumor and the entrapped MMC microspheres were detected within arterioles in the VX-2 tumors. The growth of VX-2 tumor was inhibited considerably, compared to findings in the control rabbits given conventional MMC. In the next studies, MMC microspheres were infused into the rat hepatic artery, and the levels of MMC in the hepatic vein blood were maintained at much the same concentration for over 2 hours after the infusion, in marked contrast to rapid decreases in the conventional MMC. Histologic findings revealed that MMC micro-spheres were entrapped within the hepatic arterioles for over 2 weeks and released biologically active MMC into the neighboring tissues for prolonged periods of time.</p>","PeriodicalId":77686,"journal":{"name":"Cancer drug delivery","volume":"2 3","pages":"173-81"},"PeriodicalIF":0.0000,"publicationDate":"1985-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1089/cdd.1985.2.173","citationCount":"14","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer drug delivery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1089/cdd.1985.2.173","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 14

Abstract

Biodegradable albumin microspheres containing about 5% mitomycin C (MMC) were prepared in an average diameter of 45 +/- 8 microns by heat denaturation in oil at 120 degrees C and/or cross-linking with glutaraldehyde. These MMC microspheres released, in vitro, about 20% of the contained MMC for over 3 days, and they were intra-arterially infused into albino rabbits and Wistar rats, as a preclinical model of intra-arterial infusion treatment for patients with inoperable hepatic tumor. We infused these microspheres into the femoral artery of rabbits with a VX-2 tumor implanted into the flank of the hindleg. High levels of MMC were maintained for several hours in the tumor and the entrapped MMC microspheres were detected within arterioles in the VX-2 tumors. The growth of VX-2 tumor was inhibited considerably, compared to findings in the control rabbits given conventional MMC. In the next studies, MMC microspheres were infused into the rat hepatic artery, and the levels of MMC in the hepatic vein blood were maintained at much the same concentration for over 2 hours after the infusion, in marked contrast to rapid decreases in the conventional MMC. Histologic findings revealed that MMC micro-spheres were entrapped within the hepatic arterioles for over 2 weeks and released biologically active MMC into the neighboring tissues for prolonged periods of time.

丝裂霉素C微球作为一种新的给药方法。
采用120℃油热变性和/或与戊二醛交联法制备了平均直径为45 +/- 8微米的含有5%丝裂霉素C (MMC)的可生物降解白蛋白微球。这些MMC微球在体外释放约20%的MMC,释放时间超过3天,并动脉内输注于白化兔和Wistar大鼠,作为动脉内输注治疗不能手术肝肿瘤患者的临床前模型。我们将这些微球注入兔的股动脉,并在兔后腿侧面植入VX-2肿瘤。高水平的MMC在肿瘤中维持数小时,并且在VX-2肿瘤的小动脉中检测到被包裹的MMC微球。与给予常规MMC的对照组相比,VX-2肿瘤的生长明显受到抑制。在接下来的研究中,将MMC微球输注到大鼠肝动脉中,在输注后的2小时内,肝静脉血液中MMC的浓度保持在大致相同的水平,与常规MMC的快速下降形成明显对比。组织学结果显示,MMC微球在肝小动脉内包裹超过2周,并长时间向邻近组织释放具有生物活性的MMC。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信